TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ESP Life Sciences Consulting AB
Closing information (x1000 NOK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
949
|
741
|
958 |
| Financial expenses |
57
|
0
|
5 |
| Earnings before taxes |
200
|
283
|
582 |
| EBITDA |
258
|
275
|
587 |
| Total assets |
1,432
|
1,319
|
1,159 |
| Current assets |
1,376
|
1,282
|
1,154 |
| Current liabilities |
897
|
468
|
529 |
| Equity capital |
521
|
837
|
616 |
| - share capital |
50
|
48
|
48 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
36.4%
|
63.5%
|
53.1% |
| Turnover per employee |
949
|
741
|
958 |
| Profit as a percentage of turnover |
21.1%
|
38.2%
|
60.8% |
| Return on assets (ROA) |
17.9%
|
21.5%
|
50.6% |
| Current ratio |
153.4%
|
273.9%
|
218.1% |
| Return on equity (ROE) |
38.4%
|
33.8%
|
94.5% |
| Change turnover |
172
|
-223
|
251 |
| Change turnover % |
22%
|
-23%
|
36% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.